- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Oncologists Richer, but Not Happier, Study Finds
Oncologists are slightly less satisfied with their specialty than they were a few years ago, according to the fifth consecutive annual Medscape report.
Times are changing for oncologists, as they are in medicine in general. And oncologists are slightly less satisfied with their specialty than they were a few years ago, according to the fifth consecutive annual Medscape report.
The latest figures, covering 2014 earnings, were compiled from an extensive online survey of 19,916 physicians. Around 2% (n = 398) of the respondents were oncologists. Their responses are summarized in the Oncologist Compensation Report 2015.
Overall, oncologists were well compensated; average yearly earnings were $302,000, ranking them slightly above the median for all specialties. As in previous reports, orthopedists top the income list ($421,000), followed by cardiologists ($376,000) and gastroenterologists ($370,000). At the bottom of the income list were pediatricians ($189,000), family medicine physicians ($195,000), and those in internal medicine and diabetes/endocrinology ($196,000).
Link to the article on Medscape:
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
